Search Results - "Bo, Zhiyuan"

Refine Results
  1. 1

    Association of gut microbiome and primary liver cancer: A two‐sample Mendelian randomization and case–control study by Ma, Jun, Li, Jialiang, Jin, Chen, Yang, Jinhuan, Zheng, Chongming, Chen, Kaiwen, Xie, Yitong, Yang, Yi, Bo, Zhiyuan, Wang, Jingxian, Su, Qing, Wang, Juejin, Chen, Gang, Wang, Yi

    Published in Liver international (01-01-2023)
    “…Background and Aims Observational epidemiology studies suggested a relationship between the gut microbiome and primary liver cancer. However, the causal…”
    Get full text
    Journal Article
  2. 2

    Impact of sarcopenia on postoperative outcomes after hepatectomy in older patients with intrahepatic cholangiocarcinoma: A multicentre cohort study by Zhao, Zhengxiao, Bo, Zhiyuan, Ye, Ni, Dong, Yulong, Xu, Yingfei, Wang, Binbin, Yang, Facai, Liu, Liwei, Liu, Zhendong

    Published in Liver international (01-01-2024)
    “…Background and Aims Sarcopenia is associated with poor prognosis, but its role in older patients with intrahepatic cholangiocarcinoma (ICC) is unclear. We…”
    Get full text
    Journal Article
  3. 3

    Gut microbiome as a biomarker for predicting early recurrence of HBV‐related hepatocellular carcinoma by Zheng, Chongming, Lu, Fei, Chen, Bo, Yang, Jinhuan, Yu, Haitao, Wang, Daojie, Xie, Haonan, Chen, Kaiwen, Xie, Yitong, Li, Jiacheng, Bo, Zhiyuan, Wang, Yi, Chen, Gang, Deng, Tuo

    Published in Cancer science (01-12-2023)
    “…To investigate the potential of the gut microbiome as a biomarker for predicting the early recurrence of HBV‐related hepatocellular carcinoma (HCC), we…”
    Get full text
    Journal Article
  4. 4

    Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma by Bo, Zhiyuan, Song, Jiatao, He, Qikuan, Chen, Bo, Chen, Ziyan, Xie, Xiaozai, Shu, Danyang, Chen, Kaiyu, Wang, Yi, Chen, Gang

    Published in Computers in biology and medicine (01-05-2024)
    “…Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, with an increasing incidence and poor prognosis. In the past decade, artificial…”
    Get full text
    Journal Article
  5. 5

    Effect of Sarcopenia on Survival and Health-Related Quality of Life in Patients with Hepatocellular Carcinoma after Hepatectomy by Hu, Jiawei, Yang, Jinhuan, Yu, Haitao, Bo, Zhiyuan, Chen, Kaiwen, Wang, Daojie, Xie, Yitong, Wang, Yi, Chen, Gang

    Published in Cancers (13-12-2022)
    “…Although sarcopenia has been reported as a negative prognostic factor in patients with hepatocellular carcinoma (HCC), the lack of studies with a prospective…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma by Yang, Jinhuan, Chen, Kaiwen, Zheng, Chongming, Chen, Kaiyu, Lin, Jian, Meng, Qishan, Chen, Ziyan, Deng, Liming, Yu, Haitao, Deng, Tuo, Bo, Zhiyuan, He, Qikuan, Wang, Yi, Chen, Gang

    Published in Journal of cachexia, sarcopenia and muscle (01-10-2022)
    “…Background Previous studies have indicated that sarcopenia is associated with poor post‐operative outcomes in liver cancer patients, but the studies are…”
    Get full text
    Journal Article
  8. 8

    Association between gut microbiota and gastrointestinal cancer: a two-sample bi-directional Mendelian randomization study by Su, Qing, Jin, Chen, Bo, Zhiyuan, Yang, Yi, Wang, Jingxian, Wang, Juejin, Zhou, Junxi, Chen, Yaqing, Zeng, Hao, Chen, Gang, Wang, Yi

    Published in Frontiers in microbiology (18-07-2023)
    “…The gut microbiome is closely related to gastrointestinal (GI) cancer, but the causality of gut microbiome with GI cancer has yet to be fully established. We…”
    Get full text
    Journal Article
  9. 9

    Machine Learning to Predict the Response to Lenvatinib Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma by Ma, Jun, Bo, Zhiyuan, Zhao, Zhengxiao, Yang, Jinhuan, Yang, Yan, Li, Haoqi, Yang, Yi, Wang, Jingxian, Su, Qing, Wang, Juejin, Chen, Kaiyu, Yu, Zhengping, Wang, Yi, Chen, Gang

    Published in Cancers (19-01-2023)
    “…Lenvatinib and transarterial chemoembolization (TACE) are first-line treatments for unresectable hepatocellular carcinoma (HCC), but the objective response…”
    Get full text
    Journal Article
  10. 10

    A multi-omic approach reveals utility of CD45 expression in prognosis and novel target discovery by Ye, Ni, Cai, Jie, Dong, Yulong, Chen, Huiyao, Bo, Zhiyuan, Zhao, Xiaogang, Xia, Mingyang, Han, Mei

    Published in Frontiers in genetics (17-08-2022)
    “…CD45, the leukocyte common antigen, is expressed on almost all cells of the immunological and hematological systems. CD45 expression is related to a variety of…”
    Get full text
    Journal Article
  11. 11

    Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma by He, Qikuan, Guo, Pengyi, Bo, Zhiyuan, Yu, Haitao, Yang, Jinhuan, Wang, Yi, Chen, Gang

    Published in Cancer cell international (09-08-2022)
    “…Despite the significant progress in decreasing the occurrence and mortality of hepatocellular carcinoma (HCC), it remains a public health issue worldwide on…”
    Get full text
    Journal Article
  12. 12

    A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma by Yang, Jinhuan, He, Qikuan, Lu, Fei, Chen, Kaiwen, Ni, ZhiHao, Wang, Haoyue, Zhou, Chen, Zhang, Yaosheng, Chen, Bo, Bo, Zhiyuan, Li, Jialiang, Yu, Haitao, Wang, Yi, Chen, Gang

    Published in Gut microbes (31-12-2023)
    “…Oral, gut, and tumor microbiota have been implicated as important regulators in the carcinogenesis and progression of gastrointestinal malignancies. However,…”
    Get full text
    Journal Article
  13. 13

    The clinical value of regional lymphadenectomy for intrahepatic cholangiocarcinoma by Yang, Facai, Wu, Changkang, Bo, Zhiyuan, Xu, Jian, Yi, Bin, Li, Jingdong, Qiu, Yinghe

    Published in Asian journal of surgery (01-01-2022)
    “…The aim of this study was to explore the clinical value of lymph node dissection (LND) for intrahepatic cholangiocarcinoma (ICC). Clinical and pathological…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Systematic profiling of mitochondria-related transcriptome in tumorigenesis, prognosis, and tumor immune microenvironment of intrahepatic cholangiocarcinoma: a multi-center cohort study by Chen, Bo, Lu, Mengmeng, Chen, Qiwen, Zou, Enguang, Bo, Zhiyuan, Li, Jiacheng, Zhao, Rui, Zhao, Jungang, Yu, Zhengping, Chen, Gang, Wu, Lijun

    Published in Frontiers in genetics (26-07-2024)
    “…Mitochondrial dysfunction has been shown to play a critical role in cancer biology. However, its involvement in intrahepatic cholangiocarcinoma (iCCA) remains…”
    Get full text
    Journal Article
  16. 16

    Survival Benefit of Surgical Treatment for Elderly Patients with Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study in the SEER Database by Propensity Score Matching Analysis by Chen, Kaiyu, Yu, Haitao, Yang, Jinhuan, Bo, Zhiyuan, Jin, Chen, Wu, Lijun, Wang, Yi, Chen, Gang

    Published in Current oncology (Toronto) (22-02-2023)
    “…Despite a rising trend in intrahepatic cholangiocarcinoma (ICC) incidence in the elderly population worldwide, the benefit of surgery for those patients is…”
    Get full text
    Journal Article
  17. 17

    Exploration and validation of a novel ferroptosis-related gene signature predicting the prognosis of intrahepatic cholangiocarcinoma by Yao, Xinfei, Chen, Bo, Wang, Mingxun, Zhang, Sina, He, Bangjie, Shi, Zhehao, Deng, Tuo, Bao, Wenming, Wang, Yi, Chen, Gang, Bo, Zhiyuan

    Published in Acta biochimica et biophysica Sinica (01-09-2022)
    “…Ferroptosis plays an important role in intrahepatic cholangiocarcinoma (ICC). We aim to develop a new ferroptosis-related gene signature predicting the…”
    Get full text
    Journal Article
  18. 18

    Inhibitor of Differentiation 1 (Id1) in Cancer and Cancer Therapy by Zhao, Zhengxiao, Bo, Zhiyuan, Gong, Weiyi, Guo, Yong

    Published in International journal of medical sciences (01-01-2020)
    “…The inhibitor of DNA binding (Id) proteins are regulators of cell cycle and cell differentiation. Of all Id family proteins, Id1 is mostly linked to…”
    Get full text
    Journal Article
  19. 19

    Association of glucose-lowering drug target and risk of gastrointestinal cancer: a mendelian randomization study by Yang, Yi, Chen, Bo, Zheng, Chongming, Zeng, Hao, Zhou, Junxi, Chen, Yaqing, Su, Qing, Wang, Jingxian, Wang, Juejin, Wang, Yurong, Wang, Hongli, Jin, Ruxue, Bo, Zhiyuan, Chen, Gang, Wang, Yi

    Published in Cell & bioscience (19-03-2024)
    “…Glucose-lowering drug is associated with various cancers, but the causality with gastrointestinal cancer risk is rarely reported. We aimed to explore the…”
    Get full text
    Journal Article
  20. 20

    Development of sarcopenia-based nomograms predicting postoperative complications of benign liver diseases undergoing hepatectomy: A multicenter cohort study by Bo, Zhiyuan, Chen, Ziyan, Chen, Bo, Yang, Jinhuan, Zhao, Zhengxiao, Yang, Yi, Ma, Jun, He, Qikuan, Yu, Haitao, Zheng, Chongming, Chen, Kaiwen, Wang, Yi, Chen, Gang

    Published in Frontiers in nutrition (Lausanne) (10-02-2023)
    “…Sarcopenia has a remarkable negative impact on patients with liver diseases. We aimed to evaluate the impact of preoperative sarcopenia on the short-term…”
    Get full text
    Journal Article